Skip to content
Screener

Common Stock at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$0
Johnson & Johnson logo
Johnson & JohnsonJNJ
$3.12B
Staar Surgical logo
Staar SurgicalSTAA
$502K+1.4%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$42K+10.5%
Ardelyx logo
ArdelyxARDX
500M0.0%
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$165K+1.9%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$2.34B+11.7%
Enterprise value$21.79B-1.3%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.

Filed
Apr 29, 2026, 6:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885590-26-000053
Line itemMarch 31,2026December 31,2025
Total liabilities25,58025,989
Commitments and contingencies (Note 17)
(Deficit) Equity
Common shares, no par value, unlimited shares authorized, 373,464,760 and 370,531,987 issued and outstanding at March 31, 2026 and December 31, 2025, respectively10,54210,516
Additional paid-in capital295357
Accumulated deficit(11,090)(9,667)
Accumulated other comprehensive loss(1,806)(1,760)
Total Bausch Health Companies Inc. shareholders’ deficit(2,059)(554)

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch Health Companies's common stock?
Bausch Health Companies (BHC) reported common stock of $10.54B in Q1 2026.
How has Bausch Health Companies's common stock changed year-over-year?
Bausch Health Companies's common stock increased by 0.3% year-over-year, from $10.51B to $10.54B.
What is the long-term trend for Bausch Health Companies's common stock?
Over 5 years (2020 to 2025), Bausch Health Companies's common stock has grown at a 0.6% compound annual growth rate (CAGR), from $10.23B to $10.52B.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Bausch Health Companies's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude